126 related articles for article (PubMed ID: 10547158)
1. Increase in circulating levels of monocyte chemoattractant protein-1 with aging.
Inadera H; Egashira K; Takemoto M; Ouchi Y; Matsushima K
J Interferon Cytokine Res; 1999 Oct; 19(10):1179-82. PubMed ID: 10547158
[TBL] [Abstract][Full Text] [Related]
2. Contribution of the familial and genetic factors on monocyte chemoattractant protein-1 variation in healthy human pedigrees.
Pantsulaia I; Trofimov S; Kobyliansky E; Livshits G
Cytokine; 2005 Oct; 32(2):117-23. PubMed ID: 16213155
[TBL] [Abstract][Full Text] [Related]
3. Plasma monocyte chemoattractant protein 1 is a marker for joint inflammation in rheumatoid arthritis.
Ellingsen T; Buus A; Stengaard-Pedersen K
J Rheumatol; 2001 Jan; 28(1):41-6. PubMed ID: 11196541
[TBL] [Abstract][Full Text] [Related]
4. Circulating advanced glycation end products (AGEs) and soluble form of receptor for AGEs (sRAGE) are independent determinants of serum monocyte chemoattractant protein-1 (MCP-1) levels in patients with type 2 diabetes.
Nakamura K; Yamagishi S; Adachi H; Matsui T; Kurita-Nakamura Y; Takeuchi M; Inoue H; Imaizumi T
Diabetes Metab Res Rev; 2008 Feb; 24(2):109-14. PubMed ID: 17694504
[TBL] [Abstract][Full Text] [Related]
5. Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters.
Kim CS; Park HS; Kawada T; Kim JH; Lim D; Hubbard NE; Kwon BS; Erickson KL; Yu R
Int J Obes (Lond); 2006 Sep; 30(9):1347-55. PubMed ID: 16534530
[TBL] [Abstract][Full Text] [Related]
6. Association between circulating monocyte chemoattractant protein-1 and urinary albumin excretion in nonobese Type 2 diabetic patients.
Takebayashi K; Matsumoto S; Aso Y; Inukai T
J Diabetes Complications; 2006; 20(2):98-104. PubMed ID: 16504838
[TBL] [Abstract][Full Text] [Related]
7. Elevated circulating monocyte chemoattractant protein 1 (MCP-1/CCL-2) level may be an unfavorable predictive factor to platinum- and taxane-based combination chemotherapy in patients with gastric cancer.
Tas F; Karabulut S; Serilmez M; Karabulut M; Duranyildiz D
Cancer Chemother Pharmacol; 2016 Jan; 77(1):127-31. PubMed ID: 26499899
[TBL] [Abstract][Full Text] [Related]
8. Monocyte chemoattractant protein-1 in patients with peripheral arterial disease.
Petrkova J; Szotkowska J; Hermanova Z; Lukl J; Petrek M
Mediators Inflamm; 2004 Feb; 13(1):39-43. PubMed ID: 15203564
[TBL] [Abstract][Full Text] [Related]
9. Plasma levels of the monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 are elevated in patients with acute myocardial infarction.
Matsumori A; Furukawa Y; Hashimoto T; Yoshida A; Ono K; Shioi T; Okada M; Iwasaki A; Nishio R; Matsushima K; Sasayama S
J Mol Cell Cardiol; 1997 Jan; 29(1):419-23. PubMed ID: 9040055
[TBL] [Abstract][Full Text] [Related]
10. Circulating levels of beta-chemokines in systemic lupus erythematosus.
Kaneko H; Ogasawara H; Naito T; Akimoto H; Lee S; Hishikawa T; Sekigawa I; Tokano Y; Takasaki Y; Hirose SI; Hashimoto H
J Rheumatol; 1999 Mar; 26(3):568-73. PubMed ID: 10090164
[TBL] [Abstract][Full Text] [Related]
11. Respiratory syncytial virus infection increases regulated on activation normal T cell expressed and secreted and monocyte chemotactic protein 1 levels in serum of patients with asthma and in human monocyte cultures.
Gotera J; Giuffrida M; Mavarez A; Pons H; Bermudez J; Maldonado M; Espina LM; Mosquera J; Valero N
Ann Allergy Asthma Immunol; 2012 May; 108(5):316-20. PubMed ID: 22541401
[TBL] [Abstract][Full Text] [Related]
12. Deregulated expression of monocyte chemoattractant protein-1 (MCP-1) in arterial hypertension: role in endothelial inflammation and atheromasia.
Tucci M; Quatraro C; Frassanito MA; Silvestris F
J Hypertens; 2006 Jul; 24(7):1307-18. PubMed ID: 16794480
[TBL] [Abstract][Full Text] [Related]
13. Interleukin 8 and monocyte chemoattractant protein-1 in patients with juvenile rheumatoid arthritis. Relation to onset types, disease activity, and synovial fluid leukocytes.
De Benedetti F; Pignatti P; Bernasconi S; Gerloni V; Matsushima K; Caporali R; Montecucco CM; Sozzani S; Fantini F; Martini A
J Rheumatol; 1999 Feb; 26(2):425-31. PubMed ID: 9972980
[TBL] [Abstract][Full Text] [Related]
14. Increased plasma monocyte chemoattractant protein-1 level in idiopathic pulmonary arterial hypertension.
Itoh T; Nagaya N; Ishibashi-Ueda H; Kyotani S; Oya H; Sakamaki F; Kimura H; Nakanishi N
Respirology; 2006 Mar; 11(2):158-63. PubMed ID: 16548900
[TBL] [Abstract][Full Text] [Related]
15. Pediatric asthmatic patients have low serum levels of monocyte chemoattractant protein-1.
Keszei M; Nagy A; Kozma GT; Radosits K; Tölgyesi G; Falus A; Szalai C
J Asthma; 2006; 43(5):399-404. PubMed ID: 16801146
[TBL] [Abstract][Full Text] [Related]
16. Visfatin is a positive regulator of MCP-1 in human adipocytes in vitro and in mice in vivo.
Sommer G; Kralisch S; Kloting N; Kamprad M; Schrock K; Kratzsch J; Tonjes A; Lossner U; Bluher M; Stumvoll M; Fasshauer M
Obesity (Silver Spring); 2010 Aug; 18(8):1486-92. PubMed ID: 20035281
[TBL] [Abstract][Full Text] [Related]
17. The influence of HIV infection on the correlation between plasma concentrations of monocyte chemoattractant protein-1 and carotid atherosclerosis.
Joven J; Coll B; Tous M; Ferré N; Alonso-Villaverde C; Parra S; Camps J
Clin Chim Acta; 2006 Jun; 368(1-2):114-9. PubMed ID: 16445900
[TBL] [Abstract][Full Text] [Related]
18. MCP-1 chemokine receptor CCR2 is decreased on circulating monocytes in sporadic amyotrophic lateral sclerosis (sALS).
Zhang R; Gascon R; Miller RG; Gelinas DF; Mass J; Lancero M; Narvaez A; McGrath MS
J Neuroimmunol; 2006 Oct; 179(1-2):87-93. PubMed ID: 16857270
[TBL] [Abstract][Full Text] [Related]
19. Endothelin-1 serum levels correlate with MCP-1 but not with homocysteine plasma concentration in patients with systemic sclerosis.
Peterlana D; Puccetti A; Caramaschi P; Biasi D; Beri R; Simeoni S; Corrocher R; Lunardi C
Scand J Rheumatol; 2006; 35(2):133-7. PubMed ID: 16641048
[TBL] [Abstract][Full Text] [Related]
20. Increased monocyte chemoattractant protein 1 (MCP-1/CCL-2) serum level in acute myeloid leukemia.
Mazur G; Wróbel T; Butrym A; Kapelko-Słowik K; Poreba R; Kuliczkowski K
Neoplasma; 2007; 54(4):285-9. PubMed ID: 17822317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
